Venetoclax for multiple myeloma - mechanism of action and next steps
Daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the POLLUX trial
Results of Phase III GADOLIN trial for follicular lymphoma
Results of the Phase III DASISION trial and the future of CML treatment
What are the practical considerations for monoclonal antibody infusion?